The effect of scalp cooling on alopecia during Myocet/cyclophosphamide chemotherapy.
Recruiting
- Conditions
- chemotherapy-induced alopecia
- Registration Number
- NL-OMON23571
- Lead Sponsor
- Stichting DIADOC
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 70
Inclusion Criteria
1. Female breast cancer patients, treated with Myocet and cyclophosphamide containing chemotherapy;
2. Life expectancy >=12 weeks;
Exclusion Criteria
1. Allopecia prior to start of the study;
2. Simultaneously or shortly after study start: planned skull irradiation (if allopecia is expected);
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Allopecia measured by trichometry.
- Secondary Outcome Measures
Name Time Method Subjective severity of allopecia.